ArticleJournal of physical therapy science2025
Prevalence and association of sarcopenic obesity with locomotive syndrome based on the 2024 Consensus Statement of the Japanese Working Group on Sarcopenic Obesity in community-dwelling Japanese women.
Article in Journal of physical therapy science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
[Purpose] Sarcopenia, obesity, and sarcopenic obesity (SO) impair physical function and quality of life in older women and are associated with locomotive syndrome (LS). However, the relationship between SO, as defined by the new 2024 algorithm from the Japanese Working Group on Sarcopenic Obesity (JWGSO2024), and LS remains insufficiently investigated. This study aimed to clarify the prevalence of LS and its association with physical function across four groups classified by the JWGSO2024 criteria: normal, sarcopenia, obesity, and SO. [Participants and Methods] We studied 178 community-dwelling women aged 57-91 years. Sarcopenia was diagnosed using the Japanese Strength, Ambulation, Rising from a chair, Stair climbing and history of Falling (SARC-F) questionnaire, handgrip strength, the Five Times Sit-to-Stand test, and appendicular lean mass adjusted to body mass index (ALM/BMI). Obesity was defined based on waist circumference, BMI, and body fat percentage. LS was assessed using the stand-up and two-step tests. We compared the prevalence of LS and differences in physical function among the four diagnostic groups. [Results] The SO prevalence was 3.9-6.2%. All participants in the SO group had LS. This group showed the lowest performance on the two-step test, indicating the highest risk of LS among groups. [Conclusion] SO, as defined by the JWGSO2024 criteria, was strongly associated with LS. These findings provide a scientific basis for developing LS prevention and intervention strategies for patients with SO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.